Appointment booking for Dr. Michael Hoffman, MD is currently not available.Dr. Michael Hoffman, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Michael Hoffman, MD (he/him) is a Surgeon in Atlanta, GA with over 18 years of experience. What is your opinion of Dr. Michael Hoffman, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Michael Hoffman, MD has received over $6,166 which includes payments from the following companies:
$839.72 from Mallinckrodt LLC
$652.26 from TELA Bio, Inc.
$620.46 from Davol Inc.
$433.76 from LifeCell Corporation
$426.25 from Smith & Nephew, Inc.
$408.92 from Covidien Sales LLC
$303.26 from Merck Sharp & Dohme Corporation
$296.54 from Stryker Corporation
$244.86 from Allergan Inc.
$236.88 from W. L. Gore & Associates, Inc.
$202.63 from TEI Biosciences Inc
$184.91 from HOLOGIC INC
$184.06 from Novadaq Technologies Inc.
$161.98 from Ethicon US, LLC
$137.86 from CONMED Corporation
$123.44 from Focal Therapeutics, Inc.
$112.01 from Neomend, Inc.
$105.41 from Olympus America Inc.
$95.00 from Cadence Pharmaceuticals, Inc.
$49.53 from Shire North American Group Inc
Payments received by Dr. Michael Hoffman, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!